The first (2015) award ceremony of the most influential brand selection of Chinese pharmaceutical innovation was held in Beijing

Source: China pharmaceutical promotion association on the evening of March 12, 2016, the first (2015) China pharmaceutical innovation most influential brand award ceremony jointly held by people's daily and China Pharmaceutical Innovation Promotion Association (hereinafter referred to as "China pharmaceutical promotion association") was held in Beijing Academician sang Guowei, vice chairman of the Standing Committee of the 11th National People's Congress and chief technical engineer of major new drug creation projects for major national science and technology projects, and Ms Zhao Baige, member of the Standing Committee of the National People's Congress and vice chairman of the Foreign Affairs Committee of the National People's Congress, attended the award ceremony and presented awards to the winning enterprises; Wu Haidong, deputy director of the consumer goods industry department of the Ministry of industry and information technology, and Wu Peixin, deputy director of the science and Education Department of the national health and Family Planning Commission attended the award ceremony Ceremony: President of the Chinese Academy of traditional Chinese medicine, President of Tianjin University of traditional Chinese medicine, academician Zhang Boli, vice president of major national science and technology new drug creation project, President of Shanghai University of traditional Chinese medicine, vice president of major science and technology new drug creation project, academician Chen Kaixian, director of national new drug (anti-tumor) clinical research center, cancer hospital, China Academy of Medical Sciences, Peking Union Medical College Academician Sun Yan, Professor of Clinical Oncology, academician Ge Junbo, vice president of Tongji University, director of Cardiology Department of Zhongshan Hospital Affiliated to Shanghai Fudan University, Academician Wang Guangji, Professor of China Pharmaceutical University, director of cardiology department and heart center of Peking University First Hospital, huoyong, researcher and executive deputy director of Science and Technology Committee of the Academy of Military Medical Sciences, President of Beijing shuntiande Hospital of traditional Chinese medicine, Wang Chengde Hu Xin, director of Pharmacy Department of Beijing hospital, Zhao Zhigang, director of Pharmacy Department of Beijing Tiantan Hospital Affiliated to Capital Medical University, Feng Wanyu, director of Pharmacy Department of Peking University People's Hospital and other guests attended the award ceremony and opened or presented awards to the winners Niu Yibing, President of people's network, Jiang Hualiang, director of Shanghai Institute of pharmaceutical research, Chinese Academy of Sciences, song Ruilin, executive chairman of China Pharmaceutical Association, sun Haifeng, deputy editor in chief of people's network, Jiang Jiandong, director of Institute of pharmaceutical research, Chinese Academy of Medical Sciences and vice president of China Pharmaceutical Association attended the award ceremony The award ceremony was attended by more than 100 distinguished experts, scholars, entrepreneurs and representatives of shortlisted varieties, people and enterprises active in the pharmaceutical industry Sun Haifeng, deputy editor in chief of people's network and the leader attending the ceremony, pointed out in his speech that starting from this event, we will make brand building an important fulcrum for the development of medicine, make brand economy and innovation development a new engine for promoting the sustainable development of medicine industry, and help Chinese medicine varieties and enterprises grow stronger Sun Haifeng, deputy editor in chief of renmin.com, delivered a speech to song Ruilin, executive chairman of China Pharmaceutical Association, introducing the purpose, rules and organization of the selection He pointed out that this selection activity abandoned the practice of purely taking the sales amount and enterprise scale as the basis of selection, centered on the major disease field, taking the clinical, economic and social value contribution of drugs that did not meet the clinical needs as the measurement standard, and made outstanding contributions to the Chinese pharmaceutical innovation during the 11th Five Year Plan and 12th Five Year Plan period Significant drugs, enterprises and people will be selected and praised Song Ruilin, executive chairman of China Association for the promotion of drugs, made a speech In order to ensure the "fairness, justice and openness" of the selection, the organizing committee invited many authoritative experts from the domestic drug research and development and clinical circles as judges, and also set up a public voting link The application products cover cardio cerebrovascular, tumor, infection and other treatment fields According to the statistics of people's network, the total number of public votes reached 90.16 million, the number of effective votes was 2.32 million, nearly 200000 people praised, and the number of website visits reached 165 million After four months of fierce competition, the four awards finally cost 15 units The awards are listed as follows: 1 Generic drugs with the most clinical alternative value 1 Nifedipine sustained-release tablets (2) Qingdao Huanghai Pharmaceutical Co., Ltd 2 Oxaliplatin Jiangsu Hengrui Pharmaceutical Co., Ltd 3 Clopidogrel sulfate tablets Shenzhen xinlitai Pharmaceutical Co., Ltd 2 The most influential innovator 1 Lu Xianping, President and chief scientist of Shenzhen micro core Biotechnology Co., Ltd 2 Shi Yuankai, vice president of Cancer Hospital of Chinese Academy of Medical Sciences 3 Du Ying Founder, chairman and CEO of zaiding Pharmaceutical (Shanghai) Co., Ltd 3 The most clinically valuable innovative drug 1 Cetinib hydrochloride Pharmaceutical Co., Ltd 2 Enalapril maleate folic acid tablet Shenzhen AoSA Pharmaceutical Co., Ltd 3 Conbercept ophthalmic injection Chengdu Kanghong Pharmaceutical Group Co., Ltd 4 The most innovative pharmaceutical enterprise 1 Jiangsu Hengrui Pharmaceutical Co., Ltd 2 Zhengda Tianqing Pharmaceutical Group Co., Ltd 3 Shiyao Group Co., Ltd 4 Tianshili Pharmaceutical Group Co., Ltd 5 Shenyang Sansheng Pharmaceutical Co., Ltd 6 In order to recognize the special contribution of innovators to industry innovation, Jiangsu Haosen Pharmaceutical Group Co., Ltd also allocated a special fund of 150000 yuan to reward the winners of innovators President Song Ruilin, on behalf of the organizers, presented special prizes to the winners "The most influential innovator" the winner and the Awardee "the most influential innovator" the winner and the Awardee "the most clinically valuable innovator" the winner and the Awardee "the most innovative pharmaceutical enterprise" the winner and the Awardee The innovative drugs and innovative enterprises selected in this activity are all supported by the national major new drug innovation science and technology major special project, and they have made great efforts for both innovation and brand building of the pharmaceutical industry The award is not only a recognition of the achievements of the enterprise innovation, but also a huge demonstration of the implementation of the national major new drug innovation science and technology major special project for the pharmaceutical industry innovation Big push The successful holding of the award ceremony shows that the selection activity has been highly valued and supported by the industry leaders and enterprises It will also play an important role in promoting the pharmaceutical industry to further implement the requirements of the party and the government to strengthen the brand construction, giving full play to the role of brand construction in the optimization and upgrading of the industry, and accelerating the transformation of innovation achievements in the pharmaceutical industry to ensure the sustainable development of the pharmaceutical industry Model and leading role Leaders, awarding guests and winners took a group photo with people's network and China Pharmaceutical Council, saying that in 2016, they will continue to adhere to the principle of "focusing on innovation, looking for brands" and hold the "second (2016) China pharmaceutical innovation most influential brand selection activity" In order to promote the positive energy of innovation in the pharmaceutical industry, build Chinese pharmaceutical brands, promote the continuous development of Chinese pharmaceutical and health undertakings, and make greater contributions to the protection of people's health and well-being Award ceremony venue 1 Award Ceremony venue 2